Uveitis is an inflammation of the urithe, which is part of the eye formed by the iris, the ciliary and choroid body, which results in symptoms such as red eyes, sensitivity to light and blurred vision, and can occur as a result of autoimmune diseases or infectious diseases, such as arthritis. rheumatoid arthritis, sarcoidosis, syphilis, leprosy and onchocercosis, for example.
Uveitis can be classified in anterior, posterior, intermediate and diffuse, or panuvéitis, depending on the area of the affected eye and should be treated quickly, as it can lead to complications such as cataracts, glaucoma, progressive vision loss and blindness.
- Uveitis symptoms are similar to conjunctivitis.
- But in the case of uveitis there is no itching or irritation in the eyes.
- Which is quite common in conjunctivitis.
- And can also be differentiated by the cause.
- Thus.
- In general.
- Symptoms of uveitis are:.
When uveitis symptoms last a few weeks or months and then go away, the disease is classified as acute, however, when symptoms persist for several months or years and there is no complete disappearance of symptoms, it is classified as chronic uveitis.
Uveitis is one of the symptoms of several systemic or autoimmune diseases, such as rheumatoid arthritis, spondylarthritis, juvenile rheumatoid arthritis, sarcoidosis, and Beh-et disease, for example. In addition, this may be due to infectious diseases such as toxoplasmosis, syphilis, AIDS, leprosy and onchocerchosticness.
Uveitis can also be the result of metastases or tumors in the eyes, and can occur due to the presence of foreign bodies in the eye, cornea lacerations, eye perforation, and burns caused by heat or chemicals.
Treatment of uveitis is intended to relieve symptoms and is done according to the cause, which may include the use of anti-inflammatory eye drops, corticosteroids or antibiotics, for example. In more severe cases, surgery may be recommended.
Uveitis is curable, especially when identified at an early stage, but treatment may also be necessary in the hospital for the patient to receive the drug directly into the vein. After treatment, the person needs to undergo routine tests every 6 months to 1 year to monitor eye health.